{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T14:51:14Z","timestamp":1785855074806,"version":"3.56.0"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pediatric differentiated thyroid carcinoma (DTC) is a rare disease, creating challenges for standardized care across Europe. The Netherlands published its first national pediatric DTC guideline in 2020. The 2022 European Thyroid Association (ETA) guideline introduced differences that required reconciliation with national practice. This article presents the 2026 update of the Dutch guideline, harmonized with European recommendations while retaining context-specific adaptations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The 2020 Dutch guideline was systematically compared with the ETA 2022 guideline. Differences were discussed by the national pediatric DTC working group and addressed in a structured consensus meeting to agree on revisions and adaptations relevant to the Dutch context.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Most European recommendations were adopted. Key national adaptations include performing total thyroidectomy without prior histology in Bethesda V-VI nodules with a proven BRAF mutation, expanded use of molecular diagnostics in selected nodules, and referral for genetic counseling in confirmed cases. In addition, less extensive surgery and selective omission of radioactive iodine therapy in low-risk patients were recommended, based on shared decision-making. Follow-up with neck ultrasound was limited to an initial 3-month assessment, with subsequent imaging only in case of rising thyroglobulin or anti-thyroglobulin concentrations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The 2026 Dutch guideline aligns with European recommendations while preserving context-specific adaptations. It provides a framework for consistent, patient-centered care and supports standardized clinical practice in the Netherlands, offering a model for harmonized pediatric DTC management across Europe.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ejendo\/lvag124","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T12:06:38Z","timestamp":1784721998000},"page":"R49-R55","source":"Crossref","is-referenced-by-count":0,"title":["Updated Dutch 2026 pediatric differentiated thyroid carcinoma guideline: aligning with Europe"],"prefix":"10.1093","volume":"195","author":[{"given":"Sarah C","family":"Clement","sequence":"first","affiliation":[{"name":"Department of Pediatric Endocrinology, Wilhelmina Children\u2019s Hospital (WKZ) , 3584 EA Utrecht ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1251-3583","authenticated-orcid":false,"given":"Teske B","family":"Kroondijk","sequence":"additional","affiliation":[{"name":"Department of Pediatric Endocrinology, Wilhelmina Children\u2019s Hospital (WKZ) , 3584 EA Utrecht ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2665-8738","authenticated-orcid":false,"given":"Gianni","family":"Bocca","sequence":"additional","affiliation":[{"name":"Department of Pediatric Endocrinology, Beatrix Children's Hospital, University of Groningen, University Medical Center Groningen (UMCG) , 9713 GZ Groningen ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8824-8697","authenticated-orcid":false,"given":"Arthur J A T","family":"Braat","sequence":"additional","affiliation":[{"name":"Princess M\u00e1xima Center for Pediatric Oncology , 3584 CS Utrecht ,","place":["The Netherlands"]},{"name":"Department of Radiology & Nuclear Medicine, Division Imaging & Oncology, University Medical Center Utrecht (UMCU) , 3584 CX Utrecht ,","place":["The Netherlands"]},{"name":"Department of Nuclear Medicine, Netherlands Cancer Institute Amsterdam , 1066 CX Amsterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6185-5569","authenticated-orcid":false,"given":"Miranda P","family":"Dierselhuis","sequence":"additional","affiliation":[{"name":"Princess M\u00e1xima Center for Pediatric Oncology , 3584 CS Utrecht ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6270-9483","authenticated-orcid":false,"given":"Bart","family":"de Keizer","sequence":"additional","affiliation":[{"name":"Princess M\u00e1xima Center for Pediatric Oncology , 3584 CS Utrecht ,","place":["The Netherlands"]},{"name":"Department of Radiology & Nuclear Medicine, Division Imaging & Oncology, University Medical Center Utrecht (UMCU) , 3584 CX Utrecht ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6871-1296","authenticated-orcid":false,"given":"Ronald R","family":"de Krijger","sequence":"additional","affiliation":[{"name":"Princess M\u00e1xima Center for Pediatric Oncology , 3584 CS Utrecht ,","place":["The Netherlands"]},{"name":"Department of Pathology, University Medical Center Utrecht (UMCU) , 3584 CX Utrecht ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5151-7320","authenticated-orcid":false,"given":"Schelto","family":"Kruijff","sequence":"additional","affiliation":[{"name":"Division of Surgical Oncology, Department of Surgery, University of Groningen, University Medical Center Groningen (UMCG) , 9713 GZ Groningen ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5327-1718","authenticated-orcid":false,"given":"Thera P","family":"Links","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Internal Medicine, University of Groningen, University Medical Center Groningen (UMCG) , 9713 GZ Groningen ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0484-1486","authenticated-orcid":false,"given":"Rutger A J","family":"Nievelstein","sequence":"additional","affiliation":[{"name":"Princess M\u00e1xima Center for Pediatric Oncology , 3584 CS Utrecht ,","place":["The Netherlands"]},{"name":"Department of Radiology & Nuclear Medicine, Division Imaging & Oncology, University Medical Center Utrecht (UMCU) , 3584 CX Utrecht ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3029-6071","authenticated-orcid":false,"given":"Els J M","family":"Nieveen van Dijkum","sequence":"additional","affiliation":[{"name":"Department of Surgery, Cancer Center Amsterdam, Amsterdam University Medical Center, University of Amsterdam , 1081 HV Amsterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila C E J","family":"Terwisscha van Scheltinga","sequence":"additional","affiliation":[{"name":"Princess M\u00e1xima Center for Pediatric Oncology , 3584 CS Utrecht ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J C","family":"van Treijen","sequence":"additional","affiliation":[{"name":"Department of Endocrine Oncology, University Medical Center Utrecht (UMCU) , 3584 CX Utrecht ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9677-7441","authenticated-orcid":false,"given":"A S Paul","family":"van Trotsenburg","sequence":"additional","affiliation":[{"name":"Department of Pediatric Endocrinology, Emma Children's Hospital, Amsterdam University Medical Center, University of Amsterdam , 1105 AZ Amsterdam ,","place":["The Netherlands"]},{"name":"Department of Gastroenterology Endocrinology Metabolism, Amsterdam UMC, University of Amsterdam , 1105 AZ Amsterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5379-5084","authenticated-orcid":false,"given":"Karin","family":"van der Tuin","sequence":"additional","affiliation":[{"name":"Department of Clinical Genetics, University Medical Center Groningen (UMCG) , 9713 GZ Groningen ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menno R","family":"Vriens","sequence":"additional","affiliation":[{"name":"Department of Endocrine Surgical Oncology, University Medical Center Utrecht (UMCU) , 3584 CX Utrecht ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6773-6931","authenticated-orcid":false,"given":"Hanneke M","family":"van Santen","sequence":"additional","affiliation":[{"name":"Department of Pediatric Endocrinology, Wilhelmina Children\u2019s Hospital (WKZ) , 3584 EA Utrecht ,","place":["The Netherlands"]},{"name":"Princess M\u00e1xima Center for Pediatric Oncology , 3584 CS Utrecht ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"issue":"4","key":"2026080410025467900_lvag124-B1","doi-asserted-by":"publisher","first-page":"E1683","DOI":"10.1210\/clinem\/dgaa935","article-title":"Distant metastases from childhood differentiated thyroid carcinoma: clinical course and mutational landscape","volume":"106","author":"Nies","year":"2021","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"2026080410025467900_lvag124-B2","doi-asserted-by":"publisher","first-page":"E165","DOI":"10.1210\/clinem\/dgab622","article-title":"Age, American Thyroid Association risk group, and response to therapy are prognostic factors in children with differentiated Thyroid Cancer","volume":"107","author":"Redlich","year":"2022","journal-title":"J Clin Endocrinol Metab."},{"issue":"7","key":"2026080410025467900_lvag124-B3","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1089\/thy.2014.0460","article-title":"Management guidelines for children with thyroid nodules and differentiated thyroid cancer","volume":"25","author":"Francis","year":"2015","journal-title":"Thyroid"},{"issue":"6","key":"2026080410025467900_lvag124-B4","doi-asserted-by":"publisher","DOI":"10.1530\/ETJ-22-0146","article-title":"2022 European Thyroid Association Guidelines for the management of pediatric thyroid nodules and differentiated thyroid carcinoma","volume":"11","author":"Lebbink","year":"2022","journal-title":"Eur Thyroid J"},{"issue":"6","key":"2026080410025467900_lvag124-B5","doi-asserted-by":"publisher","DOI":"10.1530\/ETJ-22-0180","article-title":"Pediatric thyroid cancer guidelines: challenges in stratifying care based on limited data","volume":"11","author":"Bauer","year":"2022","journal-title":"Eur Thyroid J"},{"issue":"2","key":"2026080410025467900_lvag124-B6","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s00268-017-4279-x","article-title":"Papillary thyroid carcinoma (PTC) in children and adults: comparison of initial presentation and long-term postoperative outcome in 4432 patients consecutively treated at the Mayo Clinic during eight decades (1936\u20132015)","volume":"42","author":"Hay","year":"2018","journal-title":"World J Surg"},{"issue":"1","key":"2026080410025467900_lvag124-B7","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1097\/CCO.0b013e3282f30220","article-title":"Differentiated thyroid cancer in children: diagnosis and management","volume":"20","author":"Dinauer","year":"2008","journal-title":"Curr Opin Oncol"},{"issue":"8","key":"2026080410025467900_lvag124-B8","doi-asserted-by":"publisher","first-page":"e27025","DOI":"10.1002\/pbc.27025","article-title":"Thyroid cancer in adolescents and young adults","volume":"65","author":"Massimino","year":"2018","journal-title":"Pediatr Blood Cancer"},{"issue":"10","key":"2026080410025467900_lvag124-B9","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.ctrv.2015.09.001","article-title":"Intermediate and long-term adverse effects of radioiodine therapy for differentiated thyroid carcinoma - a systematic review","volume":"41","author":"Clement","year":"2015","journal-title":"Cancer Treat Rev. W.B. Saunders Ltd"},{"issue":"Suppl 1","key":"2026080410025467900_lvag124-B10","doi-asserted-by":"publisher","first-page":"79","DOI":"10.4274\/Jcrpe.817","article-title":"Pediatric thyroid disease: when is surgery necessary, and who should be operating on our children?","volume":"5","author":"Breuer","year":"2013","journal-title":"J Clin Res Pediatr Endocrinol."},{"issue":"1","key":"2026080410025467900_lvag124-B11","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1159\/000484170","article-title":"Survey on paediatric differentiated thyroid cancer care in Europe","volume":"89","author":"Dekker","year":"2018","journal-title":"Horm Res Paediatr"},{"issue":"3","key":"2026080410025467900_lvag124-B12","doi-asserted-by":"publisher","DOI":"10.1530\/EC-22-0306","article-title":"Development of a pediatric differentiated thyroid carcinoma registry within the EuRRECa project: rationale and protocol","volume":"12","author":"Clement","year":"2023","journal-title":"Endocr Connect"},{"issue":"4","key":"2026080410025467900_lvag124-B13","doi-asserted-by":"publisher","first-page":"P11","DOI":"10.1530\/EJE-20-0191","article-title":"New national recommendations for the treatment of pediatric differentiated thyroid carcinoma in the Netherlands","volume":"183","author":"Lebbink","year":"2020","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"2026080410025467900_lvag124-B14","doi-asserted-by":"publisher","first-page":"e2214","DOI":"10.1210\/clinem\/dgae107","article-title":"Clinically relevant germline variants in children with nonmedullary thyroid cancer","volume":"109","author":"Van Der Tuin","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2026080410025467900_lvag124-B15","doi-asserted-by":"publisher","first-page":"6590","DOI":"10.1245\/s10434-021-09745-x","article-title":"Non-medullary thyroid cancer susceptibility genes: evidence and disease spectrum","volume":"28","author":"Zhou","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"2026080410025467900_lvag124-B16","author":"Nederlandse Internisten Vereniging"},{"issue":"8","key":"2026080410025467900_lvag124-B17","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1177\/10507256251363120","article-title":"2025 American Thyroid Association management guidelines for adult patients with differentiated thyroid cancer","volume":"35","author":"Ringel","year":"2025","journal-title":"Thyroid"},{"issue":"12","key":"2026080410025467900_lvag124-B18","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1093\/annonc\/mdz400","article-title":"Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"30","author":"Filetti","year":"2019","journal-title":"Ann Oncol."},{"issue":"3","key":"2026080410025467900_lvag124-B19","doi-asserted-by":"publisher","first-page":"P1","DOI":"10.1530\/EJE-20-0237","article-title":"Clinical considerations for the treatment of secondary differentiated thyroid carcinoma in childhood cancer survivors","volume":"183","author":"van Santen","year":"2020","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2026080410025467900_lvag124-B20","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3322\/caac.21388","article-title":"The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging","volume":"67","author":"Amin","year":"2017","journal-title":"CA Cancer J Clin"},{"issue":"10","key":"2026080410025467900_lvag124-B21","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1056\/nejmoa2111953","article-title":"Thyroidectomy without radioiodine in patients with low-risk thyroid cancer","volume":"386","author":"Leboulleux","year":"2022","journal-title":"N Engl J Med."},{"issue":"10498","key":"2026080410025467900_lvag124-B22","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/S0140-6736(25)00629-4","article-title":"Thyroidectomy with or without postoperative radioiodine for patients with low-risk differentiated thyroid cancer in the UK (IoN): a randomised, multicentre, non-inferiority trial","volume":"406","author":"Mallick","year":"2025","journal-title":"Lancet"},{"issue":"2","key":"2026080410025467900_lvag124-B23","doi-asserted-by":"publisher","first-page":"e208","DOI":"10.1210\/clinem\/dgae576","article-title":"Pediatric papillary thyroid carcinoma: outcomes after surgery without adjuvant radioactive iodine","volume":"110","author":"Castellanos","year":"2025","journal-title":"J Clin Endocrinol Metab."},{"issue":"12","key":"2026080410025467900_lvag124-B24","doi-asserted-by":"publisher","first-page":"3338","DOI":"10.1210\/clinem\/dgad322","article-title":"Outcomes of ATA low-risk pediatric thyroid cancer patients not treated with radioactive iodine therapy","volume":"108","author":"Bojarsky","year":"2023","journal-title":"J Clin Endocrinol Metab."},{"issue":"11","key":"2026080410025467900_lvag124-B25","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26595","article-title":"Early and late adverse effects of radioiodine for pediatric differentiated thyroid cancer","volume":"64","author":"Albano","year":"2017","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"2026080410025467900_lvag124-B26","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1089\/thy.2022.0576","article-title":"Does ultrasound really contribute to detection of residual\/recurrent disease after pediatric thyroidectomy? Preliminary data supporting a \u201cthyroglobulin-first\u201d approach","volume":"33","author":"Lebbink","year":"2023","journal-title":"Thyroid"},{"issue":"4","key":"2026080410025467900_lvag124-B27","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1007\/s00259-021-05586-8","article-title":"Prognostic factors in children and adolescents with differentiated thyroid carcinoma treated with total thyroidectomy and RAI: a real-life multicenter study","volume":"49","author":"Cistaro","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"2026080410025467900_lvag124-B28","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s11154-023-09835-z","article-title":"Does it work in childhood and adolescence? The predictive role of postoperative\/preablative stimulated thyroglobulin levels in paediatric thyroid cancer. A systematic review of the literature","volume":"25","author":"Piccardo","year":"2024","journal-title":"Rev Endocr Metab Disord"},{"issue":"10","key":"2026080410025467900_lvag124-B29","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1200\/JCO.21.01861","article-title":"Fusion oncogenes are associated with increased metastatic capacity and persistent disease in pediatric thyroid cancers","volume":"40","author":"Franco","year":"2022","journal-title":"J Clin Oncol"},{"issue":"1","key":"2026080410025467900_lvag124-B30","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/9959649","article-title":"Risk and prognostic factors for BRAFV600EMutations in papillary thyroid carcinoma","volume":"2022","author":"Wei","year":"2022","journal-title":"Biomed Res Int"},{"issue":"6","key":"2026080410025467900_lvag124-B31","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13061187","article-title":"The prognostic significance of BRAF gene analysis in children and adolescents with papillary thyroid carcinoma: a systematic review and meta-analysis","volume":"13","author":"Kotanidou","year":"2023","journal-title":"Diagnostics (Basel)"},{"issue":"4","key":"2026080410025467900_lvag124-B32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0125114","article-title":"Changes in the pulmonary function test after radioactive iodine treatment in patients with pulmonary metastases of differentiated thyroid cancer","volume":"10","author":"Jang","year":"2015","journal-title":"PLoS One"}],"container-title":["European Journal of Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ejendo\/advance-article-pdf\/doi\/10.1093\/ejendo\/lvag124\/69857950\/lvag124.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/195\/2\/R49\/69857950\/lvag124.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/195\/2\/R49\/69857950\/lvag124.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T14:02:58Z","timestamp":1785852178000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/195\/2\/R49\/8740377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,8,3]]}},"URL":"https:\/\/doi.org\/10.1093\/ejendo\/lvag124","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,8]]},"published":{"date-parts":[[2026,7,23]]}}}